טוען...
Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline
OBJECTIVE: To make recommendations on the use of neoadjuvant or adjuvant therapy in addition to surgery in patients with resectable gastric cancer (T1–4, N1–2, M0). OPTIONS: Neoadjuvant or adjuvant treatments compared with “curative” surgery alone. OUTCOMES: Overall survival, disease-free survival,...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Canadian Medical Association
2002
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3684659/ https://ncbi.nlm.nih.gov/pubmed/12500920 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|